Poland· PL-100468770
KIMMTRAK
A medicinal product containing tebentafuspum, registered in Poland by Immunocore Ireland Ltd..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Tebentafuspum
- Manufacturer
- Immunocore Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05056416800036
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tebentafuspum in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKIMMTRAKImmunocore Commercial LLC
- CzechiaKIMMTRAKImmunocore Ireland Limited, Dublin
- FinlandKIMMTRAKImmunocore Ireland Limited
- BelgiumKimmtrak 100 µg/0.5 mlImmunocore Ireland
- NorwayKimmtrakImmunocore Ireland Limited
- SwedenKIMMTRAK 100 mikrogram/ 0,5 ml Koncentrat till infusionsvätska, lösningImmunocore Ireland Limited
- IrelandKIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusionImmunocore Ireland Limited
- CanadaKIMMTRAKIMMUNOCORE IRELAND LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kimmtrak
- Liechtenstein · Kimmtrak
- Norway · Kimmtrak
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b82a4d8f-4259-4d6d-8bfa-afca493f2e44 GET /v1/drugs/b82a4d8f-4259-4d6d-8bfa-afca493f2e44?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "100 mcg/0,5 ml",
"packaging": "05056416800036 ¦ Rpz ¦ EU/1/22/1630/001 ¦ 145067\n1 fiol. 0,5 ml",
"substance": "Tebentafuspum 100 mcg/0,5 ml",
"common_name": "Tebentafuspum",
"pl_product_id": "100468770",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about tebentafuspum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.